Talaromyces marneffei (Segretain et al.) Samson et al.
商品貨號(hào)
B225393
Deposited As
Penicillium marneffei Segretain et al.
Strain Designations
H1140
Application
Biomedical Research and Development Material
Emerging infectious disease research
Biosafety Level
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
frozen
Storage Conditions
Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section
Type Strain
no
Preceptrol®
no
Comments
Partial yeast phase at 37C
Cell-mediated immunity
Experimental infection in athymic mouse
Medium
ATCC® Medium 325: Malt extract agar (Blakeslee's formula)
ATCC® Medium 336: Potato dextrose agar (PDA)
ATCC® Medium 2003: Czapek yeast extract agar
Growth Conditions
Temperature: 30°C
Atmosphere: Typical aerobic
Name of Depositor
N Kudeken
Special Collection
NCRR Contract
Chain of Custody
ATCC <-- N Kudeken <-- T. Sirisanthana
Isolation
Blood of AIDS patient, Chiang Mai, Thailand
References
Kudeken N, et al. Cell-mediated immunity in host resistance against infection caused by Penicillium marneffei. J. Med. Vet. Mycol. 34: 371-378, 1996. PubMed: 8971625
